Physician profile
Daniel R Smith
NPI 1043209265
$21,417.90
in general payments reported to CMS, 2019-2025
38 companies · $1,696 in 2025
The $1,696 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,324 · 2021: $1,266 · 2022: $1,275 · 2023: $1,846 · 2024: $1,425 · 2025: $1,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,822 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,821.74 |
| Education | $145.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12,205.71 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Jazz Pharmaceuticals INC. | $1,325.66 | 2019-2025 | |
| Axsome Therapeutics, INC. | $931.33 | 2023-2025 | Sunosi |
| Astrazeneca Pharmaceuticals Lp | $917.43 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Mylan Specialty L.P. | $898.03 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $818.37 | 2020-2025 | Wakix |
| Genzyme Corporation | $370.67 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $282.56 | 2023-2025 | Lumryz |
| Grifols USA, LLC | $252.79 | 2019-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $231.01 | 2020-2024 | Glassia |
| Idorsia Pharmaceuticals US INC | $200.80 | 2022-2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.40 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $180.89 | 2025 | Dupixent |
| Ucb, INC. | $115.49 | 2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $113.13 | 2022-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $82.17 | 2020-2023 | Belsomra |
| Mallinckrodt Hospital Products INC. | $74.22 | 2023-2024 | Acthar |
| Viatris Specialty LLC | $71.01 | 2025 | Yupelri |
| Electromed, INC. | $69.05 | 2019-2023 | Smartvest |
| Inspire Medical Systems, INC. | $58.82 | 2024-2025 | Inspire |
| Eisai INC. | $55.82 | 2020 | |
| Shire North American Group INC | $37.35 | 2019 | |
| 3b Medical, INC. | $37.05 | 2024-2025 | Luna |
| Philips North America LLC | $28.06 | 2019 | |
| Zoll Respicardia, INC. | $27.20 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $24.88 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $24.83 | 2023 | Opsumit, Uptravi |
| Inogen, INC. | $23.72 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Resmed Corp | $21.97 | 2020 | |
| Verona Pharma, INC. | $20.92 | 2025 | Ohtuvayre |
| Mallinckrodt Enterprises LLC | $19.60 | 2019 | |
| Hikma Pharmaceuticals USA | $19.12 | 2025 | Ryaltris |
| Genentech USA, INC. | $18.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.07 | 2019 | |
| Baxter Healthcare | $16.51 | 2023 | Hillrom - Life 2000 Ventilation System |
| Ani Pharmaceuticals, INC. | $15.73 | 2023 | Purified Cortrophin Gel |
| Circassia INC. | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.